| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 9.42e-05 | 18 | 100 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.65e-04 | 28 | 100 | 3 | GO:0051959 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 6.81e-06 | 145 | 100 | 7 | GO:0001578 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | RAE1 INO80 GBA2 TTK DNAH7 TBC1D32 CCDC66 DST DNAH17 FBXW5 NAV1 DNAI4 RP1 NIN | 9.67e-06 | 720 | 100 | 14 | GO:0000226 |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell differentiation | 2.36e-05 | 12 | 100 | 3 | GO:0032825 | |
| GeneOntologyBiologicalProcess | mucosa-associated lymphoid tissue development | 3.05e-05 | 13 | 100 | 3 | GO:0048537 | |
| GeneOntologyBiologicalProcess | Peyer's patch development | 3.05e-05 | 13 | 100 | 3 | GO:0048541 | |
| GeneOntologyBiologicalProcess | microtubule-based process | RAE1 SYBU INO80 GBA2 TTK DNAH7 TBC1D32 CCDC66 DST DNAH17 FBXW5 NAV1 DNAI4 RP1 DNAH9 NIN | 4.75e-05 | 1058 | 100 | 16 | GO:0007017 |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 6.96e-05 | 3 | 100 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 1.38e-04 | 21 | 100 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | axoneme assembly | 1.90e-04 | 109 | 100 | 5 | GO:0035082 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 6.01e-06 | 25 | 101 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | microtubule | RPGRIP1L SYBU INO80 DNAH7 CCDC66 DST DNAH17 NAV1 RP1 DNAH9 NIN | 5.35e-05 | 533 | 101 | 11 | GO:0005874 |
| GeneOntologyCellularComponent | PcG protein complex | 1.16e-04 | 52 | 101 | 4 | GO:0031519 | |
| GeneOntologyCellularComponent | dynein complex | 1.35e-04 | 54 | 101 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.52e-04 | 317 | 101 | 8 | GO:0032838 | |
| GeneOntologyCellularComponent | cytoplasmic region | 3.60e-04 | 360 | 101 | 8 | GO:0099568 | |
| GeneOntologyCellularComponent | axoneme | 5.09e-04 | 207 | 101 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 5.22e-04 | 208 | 101 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RAE1 BICRA MCM7 INO80 EZH1 STAT5A STAT5B PHC3 SCML2 CEBPZ AFF1 BICRAL ASXL2 SAP130 KDM6A SMAD9 | 9.02e-04 | 1377 | 101 | 16 | GO:0140513 |
| GeneOntologyCellularComponent | microtubule associated complex | 1.11e-03 | 161 | 101 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | RPGRIP1L SYBU INO80 DNAH7 CCDC66 DST PDLIM3 DNAH17 NAV1 RP1 DNAH9 NIN | 1.32e-03 | 899 | 101 | 12 | GO:0099513 |
| GeneOntologyCellularComponent | outer dynein arm | 1.48e-03 | 12 | 101 | 2 | GO:0036157 | |
| GeneOntologyCellularComponent | chromatin | FOXM1 CUX2 BICRA FOXB2 MCM7 INO80 RFX7 EZH1 STAT5A STAT5B YEATS2 SCML2 BRD2 BICRAL SAP130 SMAD9 | 1.91e-03 | 1480 | 101 | 16 | GO:0000785 |
| GeneOntologyCellularComponent | GBAF complex | 2.03e-03 | 14 | 101 | 2 | GO:0140288 | |
| Domain | GSCR1_dom | 2.67e-05 | 2 | 97 | 2 | IPR015671 | |
| Domain | GLTSCR1 | 2.67e-05 | 2 | 97 | 2 | PF15249 | |
| Domain | STAT_TF_prot_interaction | 5.51e-04 | 7 | 97 | 2 | IPR013799 | |
| Domain | STAT_TF_DNA-bd_sub | 5.51e-04 | 7 | 97 | 2 | IPR012345 | |
| Domain | STAT | 5.51e-04 | 7 | 97 | 2 | IPR001217 | |
| Domain | STAT_TF_coiled-coil | 5.51e-04 | 7 | 97 | 2 | IPR015988 | |
| Domain | - | 5.51e-04 | 7 | 97 | 2 | 2.60.40.630 | |
| Domain | STAT_int | 5.51e-04 | 7 | 97 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 5.51e-04 | 7 | 97 | 2 | IPR013801 | |
| Domain | STAT_bind | 5.51e-04 | 7 | 97 | 2 | PF02864 | |
| Domain | STAT_int | 5.51e-04 | 7 | 97 | 2 | PF02865 | |
| Domain | - | 5.51e-04 | 7 | 97 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 5.51e-04 | 7 | 97 | 2 | PF01017 | |
| Domain | - | 5.51e-04 | 7 | 97 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_alpha | 7.32e-04 | 8 | 97 | 2 | IPR013800 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.33e-03 | 14 | 97 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.33e-03 | 14 | 97 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.33e-03 | 14 | 97 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.33e-03 | 14 | 97 | 2 | PF08393 | |
| Domain | MT | 2.33e-03 | 14 | 97 | 2 | PF12777 | |
| Domain | AAA_8 | 2.33e-03 | 14 | 97 | 2 | PF12780 | |
| Domain | DHC_fam | 2.68e-03 | 15 | 97 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.68e-03 | 15 | 97 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.68e-03 | 15 | 97 | 2 | PF03028 | |
| Domain | CARD | 3.06e-03 | 16 | 97 | 2 | SM00114 | |
| Domain | AAA+_ATPase | 6.75e-03 | 144 | 97 | 4 | IPR003593 | |
| Domain | AAA | 6.75e-03 | 144 | 97 | 4 | SM00382 | |
| Domain | CARD | 9.24e-03 | 28 | 97 | 2 | PF00619 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 1.65e-05 | 11 | 67 | 3 | M27195 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 6.65e-05 | 17 | 67 | 3 | M47905 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 2.20e-04 | 5 | 67 | 2 | M49006 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 2.20e-04 | 5 | 67 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 2.20e-04 | 5 | 67 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 2.47e-04 | 26 | 67 | 3 | M47923 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.77e-04 | 27 | 67 | 3 | M47755 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 3.30e-04 | 6 | 67 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 3.30e-04 | 6 | 67 | 2 | MM15621 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 4.60e-04 | 7 | 67 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 4.60e-04 | 7 | 67 | 2 | M47430 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 4.60e-04 | 7 | 67 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 4.60e-04 | 7 | 67 | 2 | M47646 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 4.60e-04 | 7 | 67 | 2 | M27907 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 4.86e-04 | 77 | 67 | 4 | M27226 | |
| Pathway | WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS | 5.53e-04 | 34 | 67 | 3 | M48081 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 5.84e-04 | 143 | 67 | 5 | M39591 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 6.76e-04 | 84 | 67 | 4 | MM14929 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 7.84e-04 | 9 | 67 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 7.84e-04 | 9 | 67 | 2 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 7.84e-04 | 9 | 67 | 2 | M8066 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119 | 8.94e-04 | 40 | 67 | 3 | M47917 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 9.77e-04 | 10 | 67 | 2 | M27898 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 9.77e-04 | 10 | 67 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 9.77e-04 | 10 | 67 | 2 | MM15618 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.11e-03 | 43 | 67 | 3 | M47669 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.19e-03 | 11 | 67 | 2 | MM15578 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.26e-03 | 45 | 67 | 3 | M47670 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 1.42e-03 | 12 | 67 | 2 | M27893 | |
| Pathway | PID_PTP1B_PATHWAY | 1.92e-03 | 52 | 67 | 3 | M50 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.95e-03 | 14 | 67 | 2 | M27858 | |
| Pathway | PID_IL5_PATHWAY | 1.95e-03 | 14 | 67 | 2 | M135 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 2.25e-03 | 15 | 67 | 2 | M552 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 2.25e-03 | 15 | 67 | 2 | MM1412 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M17681 | |
| Pathway | WP_FOXP3_IN_COVID19 | 2.25e-03 | 15 | 67 | 2 | M42573 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 2.25e-03 | 15 | 67 | 2 | MM14536 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 2.56e-03 | 16 | 67 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 2.56e-03 | 16 | 67 | 2 | MM1420 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 2.56e-03 | 16 | 67 | 2 | M41733 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 2.56e-03 | 16 | 67 | 2 | MM15710 | |
| Pubmed | UBAP2 BICRA TNRC6B INO80 RFX7 UBN2 RBM20 EMSY STAT5A STAT5B YEATS2 PHC3 CSE1L DST BRD2 ZNF608 FUBP1 MDC1 BANP ASXL2 SAP130 FUBP3 KDM6A GARRE1 ILVBL ZC3HAV1 NPAT | 4.09e-15 | 1429 | 101 | 27 | 35140242 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | FOXM1 ZSWIM8 RPGRIP1L RAE1 HIPK1 ZGRF1 ARHGAP17 MCM7 ZCCHC2 UBN2 TTK RBM20 EMSY YEATS2 BANP NAV1 GARRE1 NIN | 1.00e-13 | 588 | 101 | 18 | 38580884 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FOXM1 CAST IQCN RFX7 VIRMA EMSY YEATS2 PHC3 ESYT2 SCML2 BRD2 FUBP1 SIPA1L1 MDC1 AFF1 KDM6A ZC3HAV1 | 9.49e-11 | 774 | 101 | 17 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RAE1 INO80 RFX7 ARHGAP11A UBN2 EMSY YEATS2 PHC3 ESYT2 SCML2 DST BRD2 CEBPZ MDC1 BANP ASXL2 SAP130 FUBP3 KDM6A ILVBL ZC3HAV1 | 1.24e-10 | 1294 | 101 | 21 | 30804502 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RAD52 BICRA CAST TNRC6B WDR27 DAP IQCN UBN2 STAT5B SHISA9 YEATS2 ESYT2 ZNF608 FUBP1 BANP NAV1 AFF1 SAP130 KDM6A MAML3 VPS13B ZC3HAV1 | 2.46e-10 | 1489 | 101 | 22 | 28611215 |
| Pubmed | AMBN ZSWIM8 RAE1 BICRA TNRC6B FASTKD5 INO80 EZH1 YEATS2 ARHGEF33 BRD2 ZNF608 SIPA1L1 BICRAL SAP130 GARRE1 ILVBL NIN | 3.44e-09 | 1116 | 101 | 18 | 31753913 | |
| Pubmed | ZSCAN4 ZGRF1 TNRC6B MCM7 BIRC6 RBM20 YEATS2 PHC3 DST ZNF608 NAV1 NPAT | 3.53e-09 | 418 | 101 | 12 | 34709266 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | RAE1 BICRA ZSCAN4 INO80 RFX7 UBN2 EMSY ZNF608 MDC1 ASXL2 KDM6A | 6.69e-09 | 351 | 101 | 11 | 38297188 |
| Pubmed | UBAP2 CAST TNRC6B MCM7 UBN2 EMSY YEATS2 SCML2 CEBPZ MDC1 SAP130 KDM6A ZC3HAV1 | 7.55e-09 | 549 | 101 | 13 | 38280479 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | UBAP2 RAE1 BICRA CAST UBN2 EMSY YEATS2 PHC3 SCML2 BRD2 CEBPZ FUBP1 MDC1 SAP130 FUBP3 NPAT | 1.64e-08 | 954 | 101 | 16 | 36373674 |
| Pubmed | 2.11e-08 | 225 | 101 | 9 | 12168954 | ||
| Pubmed | 2.96e-08 | 234 | 101 | 9 | 36243803 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 23696567 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | UBAP2 COBLL1 ARHGAP17 RFX7 TTK VIRMA DNAH7 ESYT2 DST SIPA1L1 NAV1 PLCH1 GARRE1 ZC3HAV1 | 2.05e-07 | 861 | 101 | 14 | 36931259 |
| Pubmed | UBAP2 RPGRIP1L TNRC6B ARHGAP17 FASTKD5 BIRC6 YEATS2 SCML2 CEBPZ MDC1 BANP NAV1 PLCH1 | 2.17e-07 | 733 | 101 | 13 | 34672954 | |
| Pubmed | Growth hormone enhances the recovery of hypoglycemia via ventromedial hypothalamic neurons. | 2.37e-07 | 5 | 101 | 3 | 31366244 | |
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 17726024 | ||
| Pubmed | 3.23e-07 | 152 | 101 | 7 | 38360978 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 4.12e-07 | 232 | 101 | 8 | 25515538 | |
| Pubmed | 4.72e-07 | 6 | 101 | 3 | 17412818 | ||
| Pubmed | 5.88e-07 | 103 | 101 | 6 | 10574462 | ||
| Pubmed | 7.39e-07 | 446 | 101 | 10 | 24255178 | ||
| Pubmed | Transcriptional and physiological roles for STAT proteins in leptin action. | 8.25e-07 | 7 | 101 | 3 | 30718218 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RPGRIP1L CAST TNRC6B TTK DNAH7 EMSY ESYT2 CCDC66 PDLIM3 SIPA1L1 GARRE1 ZC3HAV1 NIN | 1.19e-06 | 853 | 101 | 13 | 28718761 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.67e-06 | 123 | 101 | 6 | 26912792 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 1.88e-06 | 495 | 101 | 10 | 27705803 | |
| Pubmed | FOXM1 RAE1 TNRC6B ARHGAP11A UBN2 CCDC66 DST BRD2 ZNF608 NAV1 NIN | 2.88e-06 | 645 | 101 | 11 | 25281560 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 4.03e-06 | 315 | 101 | 8 | 26777405 | |
| Pubmed | TNRC6B INO80 UBN2 VIRMA EMSY PHC3 ESYT2 SCML2 C1orf21 DST BRD2 CEBPZ SIPA1L1 MDC1 ILVBL ZC3HAV1 | 6.47e-06 | 1497 | 101 | 16 | 31527615 | |
| Pubmed | 6.90e-06 | 339 | 101 | 8 | 30415952 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 7.75e-06 | 457 | 101 | 9 | 32344865 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23151802 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26999798 | ||
| Pubmed | Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. | 8.35e-06 | 2 | 101 | 2 | 20233708 | |
| Pubmed | Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development. | 8.35e-06 | 2 | 101 | 2 | 16775227 | |
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 8.35e-06 | 2 | 101 | 2 | 31443474 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17447893 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 12377952 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 8.35e-06 | 2 | 101 | 2 | 21127177 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16289657 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 25552366 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 25470773 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 36326914 | ||
| Pubmed | The reactive pyruvate metabolite dimethylglyoxal mediates neurological consequences of diabetes. | 8.35e-06 | 2 | 101 | 2 | 38987239 | |
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 8.35e-06 | 2 | 101 | 2 | 21431790 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16115927 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23275557 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 28500076 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21826656 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 11867689 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 7720707 | ||
| Pubmed | Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. | 8.35e-06 | 2 | 101 | 2 | 15980098 | |
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 8.35e-06 | 2 | 101 | 2 | 27264955 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 15340066 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22159083 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 20008792 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 33199496 | ||
| Pubmed | STAT5A/B gene locus undergoes amplification during human prostate cancer progression. | 8.35e-06 | 2 | 101 | 2 | 23660011 | |
| Pubmed | Role of Stat5 in type I interferon-signaling and transcriptional regulation. | 8.35e-06 | 2 | 101 | 2 | 12901872 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 28074064 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 36755813 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16502315 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 12217382 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 25333863 | ||
| Pubmed | A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. | 8.35e-06 | 2 | 101 | 2 | 12421978 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 9852045 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 31599926 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19966185 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21704724 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 10594041 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21036145 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 10486277 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 38618957 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 8.35e-06 | 2 | 101 | 2 | 16840779 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 8.35e-06 | 2 | 101 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 8.35e-06 | 2 | 101 | 2 | 30377054 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23565285 | ||
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 8.35e-06 | 2 | 101 | 2 | 32790723 | |
| Pubmed | Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone. | 8.35e-06 | 2 | 101 | 2 | 8732682 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18492722 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26717567 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 10066807 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 10835485 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 35464049 | ||
| Pubmed | The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5. | 8.35e-06 | 2 | 101 | 2 | 32281944 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18286195 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 8.35e-06 | 2 | 101 | 2 | 23773921 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 8631883 | ||
| Pubmed | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. | 8.35e-06 | 2 | 101 | 2 | 11030348 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 8.35e-06 | 2 | 101 | 2 | 24878107 | |
| Pubmed | Adipocyte STAT5 deficiency does not affect blood glucose homeostasis in obese mice. | 8.35e-06 | 2 | 101 | 2 | 34818373 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 12847485 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 12835478 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 7568026 | ||
| Pubmed | Identification of STAT5A and STAT5B target genes in human T cells. | 8.35e-06 | 2 | 101 | 2 | 24497979 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23465551 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 11756158 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17536022 | ||
| Pubmed | STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line. | 8.35e-06 | 2 | 101 | 2 | 17382296 | |
| Pubmed | STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. | 8.35e-06 | 2 | 101 | 2 | 17911616 | |
| Interaction | NUP43 interactions | RAE1 TNRC6B INO80 UBN2 VIRMA EMSY YEATS2 PHC3 DST ZNF608 CEBPZ MDC1 ASXL2 DNAH9 NPAT | 3.87e-07 | 625 | 99 | 15 | int:NUP43 |
| Interaction | HDAC1 interactions | NFE4 ZGRF1 TNRC6B MCM7 USP37 BIRC6 VIRMA RBM20 EMSY STAT5A TBC1D32 YEATS2 DST ZNF608 BANP NAV1 AFF1 SAP130 NPAT | 1.61e-06 | 1108 | 99 | 19 | int:HDAC1 |
| Interaction | SYNE3 interactions | TNRC6B ZCCHC2 TTK YEATS2 ESYT2 CCDC66 DST SIPA1L1 NAV1 GARRE1 ZC3HAV1 NIN | 1.84e-06 | 444 | 99 | 12 | int:SYNE3 |
| Interaction | SAMD4B interactions | 2.35e-06 | 122 | 99 | 7 | int:SAMD4B | |
| Interaction | R3HDM2 interactions | 3.41e-06 | 129 | 99 | 7 | int:R3HDM2 | |
| Interaction | ASF1A interactions | 3.82e-06 | 249 | 99 | 9 | int:ASF1A | |
| Interaction | PHF21A interactions | 7.29e-06 | 343 | 99 | 10 | int:PHF21A | |
| Interaction | DAZL interactions | 7.40e-06 | 145 | 99 | 7 | int:DAZL | |
| Interaction | HNF4A interactions | 8.53e-06 | 275 | 99 | 9 | int:HNF4A | |
| Interaction | SNRNP40 interactions | MCM7 USP37 UBN2 VIRMA RBM20 EMSY YEATS2 PHC3 ZNF608 CEBPZ FUBP1 MDC1 NPAT | 1.42e-05 | 637 | 99 | 13 | int:SNRNP40 |
| Interaction | CEP128 interactions | 1.58e-05 | 297 | 99 | 9 | int:CEP128 | |
| Interaction | UBAP2L interactions | 1.62e-05 | 298 | 99 | 9 | int:UBAP2L | |
| Interaction | CEP162 interactions | 1.93e-05 | 168 | 99 | 7 | int:CEP162 | |
| Interaction | YWHAH interactions | UBAP2 RPGRIP1L RAE1 COBLL1 ARHGAP17 RFX7 TTK VIRMA DNAH7 ESYT2 DST SIPA1L1 NAV1 PLCH1 GARRE1 ZC3HAV1 NIN | 2.43e-05 | 1102 | 99 | 17 | int:YWHAH |
| Interaction | NFYC interactions | 2.70e-05 | 177 | 99 | 7 | int:NFYC | |
| Interaction | SMG7 interactions | 2.77e-05 | 319 | 99 | 9 | int:SMG7 | |
| Interaction | SMC5 interactions | UBAP2 RAE1 BICRA CAST UBN2 EMSY YEATS2 PHC3 SCML2 BRD2 CEBPZ FUBP1 MDC1 SAP130 FUBP3 NPAT | 2.80e-05 | 1000 | 99 | 16 | int:SMC5 |
| Interaction | YTHDF3 interactions | 2.89e-05 | 246 | 99 | 8 | int:YTHDF3 | |
| Interaction | KDM1A interactions | RPGRIP1L ZGRF1 TNRC6B MCM7 BIRC6 VIRMA RBM20 YEATS2 PHC3 DST ZNF608 NAV1 SMAD9 NPAT NIN | 5.35e-05 | 941 | 99 | 15 | int:KDM1A |
| Interaction | BICRAL interactions | 5.84e-05 | 43 | 99 | 4 | int:BICRAL | |
| Interaction | CEP135 interactions | 5.89e-05 | 272 | 99 | 8 | int:CEP135 | |
| Interaction | FEV interactions | 6.46e-05 | 203 | 99 | 7 | int:FEV | |
| Interaction | N4BP2 interactions | 7.74e-05 | 89 | 99 | 5 | int:N4BP2 | |
| Interaction | YWHAG interactions | UBAP2 RPGRIP1L COBLL1 ARHGAP17 USP37 RFX7 TTK VIRMA DNAH7 ESYT2 CSE1L DST SIPA1L1 NAV1 PLCH1 GARRE1 ZC3HAV1 | 1.14e-04 | 1248 | 99 | 17 | int:YWHAG |
| Interaction | ERG interactions | 1.16e-04 | 223 | 99 | 7 | int:ERG | |
| Interaction | EIF4ENIF1 interactions | 1.16e-04 | 300 | 99 | 8 | int:EIF4ENIF1 | |
| Interaction | CPEB4 interactions | 1.21e-04 | 156 | 99 | 6 | int:CPEB4 | |
| Interaction | PIK3C2G interactions | 1.42e-04 | 4 | 99 | 2 | int:PIK3C2G | |
| Interaction | CNOT9 interactions | 1.44e-04 | 231 | 99 | 7 | int:CNOT9 | |
| Interaction | MEN1 interactions | UBAP2 RAE1 SYBU INO80 EMSY SCML2 ZNF608 CEBPZ FUBP1 MDC1 SAP130 FUBP3 KDM6A ZC3HAV1 NIN | 1.45e-04 | 1029 | 99 | 15 | int:MEN1 |
| Interaction | SFN interactions | RAE1 COBLL1 ARHGAP11A VIRMA IVL DST SIPA1L1 BANP NAV1 PLCH1 SAP130 GARRE1 | 1.47e-04 | 692 | 99 | 12 | int:SFN |
| Interaction | ANKHD1-EIF4EBP3 interactions | 1.93e-04 | 108 | 99 | 5 | int:ANKHD1-EIF4EBP3 | |
| Interaction | EYA4 interactions | 1.97e-04 | 243 | 99 | 7 | int:EYA4 | |
| Interaction | EGR2 interactions | 2.00e-04 | 171 | 99 | 6 | int:EGR2 | |
| Interaction | EN1 interactions | 2.10e-04 | 110 | 99 | 5 | int:EN1 | |
| Interaction | ANKRD36B interactions | 2.16e-04 | 60 | 99 | 4 | int:ANKRD36B | |
| Interaction | WWTR1 interactions | 2.33e-04 | 422 | 99 | 9 | int:WWTR1 | |
| Interaction | BAG2 interactions | UBAP2 ARHGAP17 UBN2 VIRMA YEATS2 PHC3 BRD2 MDC1 FBXW5 KDM6A VPS13B | 2.39e-04 | 622 | 99 | 11 | int:BAG2 |
| Interaction | NUP35 interactions | 2.42e-04 | 424 | 99 | 9 | int:NUP35 | |
| Interaction | ZNF704 interactions | 2.44e-04 | 25 | 99 | 3 | int:ZNF704 | |
| Interaction | CPLANE1 interactions | 2.44e-04 | 25 | 99 | 3 | int:CPLANE1 | |
| Interaction | CEP152 interactions | 2.55e-04 | 179 | 99 | 6 | int:CEP152 | |
| Interaction | CEP63 interactions | 2.55e-04 | 179 | 99 | 6 | int:CEP63 | |
| Interaction | ELF4 interactions | 2.59e-04 | 115 | 99 | 5 | int:ELF4 | |
| Interaction | HELZ interactions | 2.77e-04 | 257 | 99 | 7 | int:HELZ | |
| Interaction | CPAP interactions | 2.79e-04 | 182 | 99 | 6 | int:CPAP | |
| Interaction | ALG13 interactions | 2.88e-04 | 183 | 99 | 6 | int:ALG13 | |
| Interaction | ILVBL interactions | 2.88e-04 | 183 | 99 | 6 | int:ILVBL | |
| Interaction | FBXO42 interactions | 2.91e-04 | 259 | 99 | 7 | int:FBXO42 | |
| Interaction | LSM14A interactions | 2.98e-04 | 260 | 99 | 7 | int:LSM14A | |
| Interaction | KRT8 interactions | 3.22e-04 | 441 | 99 | 9 | int:KRT8 | |
| Interaction | CBX3 interactions | COBLL1 USP37 EZH1 UBN2 VIRMA YEATS2 SCML2 BRD2 MDC1 ASXL2 SAP130 | 3.30e-04 | 646 | 99 | 11 | int:CBX3 |
| Interaction | ENTR1 interactions | 3.32e-04 | 188 | 99 | 6 | int:ENTR1 | |
| Interaction | HNF1B interactions | 3.52e-04 | 190 | 99 | 6 | int:HNF1B | |
| Interaction | FAM120C interactions | 3.62e-04 | 191 | 99 | 6 | int:FAM120C | |
| Interaction | KANSL2 interactions | 3.92e-04 | 70 | 99 | 4 | int:KANSL2 | |
| Interaction | FOXP2 interactions | 3.92e-04 | 70 | 99 | 4 | int:FOXP2 | |
| Interaction | NIN interactions | 3.93e-04 | 359 | 99 | 8 | int:NIN | |
| Interaction | BANP interactions | 4.36e-04 | 277 | 99 | 7 | int:BANP | |
| Interaction | TNRC6A interactions | 4.65e-04 | 280 | 99 | 7 | int:TNRC6A | |
| Interaction | PRLR interactions | 4.68e-04 | 31 | 99 | 3 | int:PRLR | |
| Interaction | CRK interactions | 4.79e-04 | 370 | 99 | 8 | int:CRK | |
| Interaction | CNOT8 interactions | 4.84e-04 | 74 | 99 | 4 | int:CNOT8 | |
| Interaction | KDM5A interactions | 4.84e-04 | 74 | 99 | 4 | int:KDM5A | |
| Interaction | TNRC6B interactions | 4.85e-04 | 282 | 99 | 7 | int:TNRC6B | |
| Interaction | ALAS2 interactions | 4.94e-04 | 7 | 99 | 2 | int:ALAS2 | |
| Interaction | SETD1B interactions | 5.10e-04 | 75 | 99 | 4 | int:SETD1B | |
| Interaction | DPY30 interactions | 5.13e-04 | 204 | 99 | 6 | int:DPY30 | |
| Interaction | TRIM66 interactions | 5.26e-04 | 205 | 99 | 6 | int:TRIM66 | |
| Interaction | AGO2 interactions | 5.27e-04 | 472 | 99 | 9 | int:AGO2 | |
| Interaction | TLE3 interactions | 5.33e-04 | 376 | 99 | 8 | int:TLE3 | |
| Interaction | PUM1 interactions | 5.38e-04 | 287 | 99 | 7 | int:PUM1 | |
| Interaction | TJP2 interactions | 5.49e-04 | 288 | 99 | 7 | int:TJP2 | |
| Interaction | SIPA1L2 interactions | 5.60e-04 | 136 | 99 | 5 | int:SIPA1L2 | |
| Cytoband | 4q21 | 8.87e-04 | 20 | 101 | 2 | 4q21 | |
| Cytoband | 8q22.2 | 1.18e-03 | 23 | 101 | 2 | 8q22.2 | |
| Cytoband | 1q25 | 1.50e-03 | 26 | 101 | 2 | 1q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p22 | 1.60e-03 | 104 | 101 | 3 | chr2p22 | |
| Cytoband | 8q12.1 | 1.87e-03 | 29 | 101 | 2 | 8q12.1 | |
| Cytoband | 17q11.2 | 1.88e-03 | 110 | 101 | 3 | 17q11.2 | |
| GeneFamily | Dyneins, axonemal | 2.40e-05 | 17 | 61 | 3 | 536 | |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_UP | 9.45e-07 | 198 | 100 | 8 | M3171 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | TOX COBLL1 CAST TNRC6B STAT5B TG ESYT2 ZNF608 BANP ASXL2 ZC3HAV1 | 3.22e-06 | 498 | 100 | 11 | M1741 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | TOX COBLL1 CAST TNRC6B STAT5B TG ESYT2 ZNF608 BANP ASXL2 ZC3HAV1 | 3.83e-06 | 507 | 100 | 11 | MM1030 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 5.99e-06 | 180 | 100 | 7 | M8239 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | RAE1 HIPK1 ARMCX5 VIRMA EMSY CCDC66 CEBPZ FUBP1 SIPA1L1 SAP130 FUBP3 KDM6A | 1.10e-05 | 680 | 100 | 12 | M41089 |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP | 4.44e-05 | 167 | 100 | 6 | M2995 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_2_DN | 5.29e-05 | 344 | 100 | 8 | M2239 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | FOXM1 CELF4 UBAP2 TOX SCG5 ZGRF1 MCM7 USP37 ARHGAP11A TTK NPAT | 5.78e-05 | 680 | 100 | 11 | MM456 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | FOXM1 RAE1 CAST CASP4 MCM7 ARHGAP11A TTK PGM3 ESYT2 CSE1L CEBPZ | 9.72e-05 | 721 | 100 | 11 | M10237 |
| Coexpression | GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN | 1.02e-04 | 194 | 100 | 6 | M4912 | |
| Coexpression | GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN | 1.05e-04 | 195 | 100 | 6 | M7382 | |
| Coexpression | GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN | 1.17e-04 | 199 | 100 | 6 | M6711 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_UP | 1.20e-04 | 200 | 100 | 6 | M3962 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | FOXM1 BICRA SCG5 COBLL1 FASTKD5 ARMCX5 ZCCHC2 BIRC6 PGM3 TBC1D32 DST SUSD5 FAM222B MDC1 NAV1 PLCH1 | 1.57e-05 | 994 | 100 | 16 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.13e-05 | 71 | 100 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k2_1000 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.28e-07 | 186 | 101 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.93e-07 | 193 | 101 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.61e-07 | 199 | 101 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-06 | 165 | 101 | 6 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 2.26e-06 | 167 | 101 | 6 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-06 | 186 | 101 | 6 | f5468e03321ea2083e223eb0d92c3a9307039569 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-06 | 190 | 101 | 6 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-06 | 190 | 101 | 6 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.76e-06 | 190 | 101 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.21e-06 | 193 | 101 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 5.69e-06 | 196 | 101 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 5.69e-06 | 196 | 101 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.39e-06 | 200 | 101 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.28e-05 | 149 | 101 | 5 | a34d095b8e0fe59d69d84e4fd2fe4ccb82f92e4f | |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.43e-05 | 151 | 101 | 5 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 162 | 101 | 5 | 04a96442e0fcdb6a65b9e45044021677f9f53d38 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 162 | 101 | 5 | 7adb3e279526e1f21033c10af0a0058258f21842 | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.62e-05 | 164 | 101 | 5 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-05 | 167 | 101 | 5 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 169 | 101 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_HSPB3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.29e-05 | 170 | 101 | 5 | 985c6c9e3c593ed0628a481f06c2c91b2ab5d746 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-05 | 171 | 101 | 5 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.54e-05 | 172 | 101 | 5 | c6bc78fd63c9479a84ec0552b55c89750cad0fa5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.54e-05 | 172 | 101 | 5 | bfb87a281a9cf6ad45b310bf8104fc0ab382b549 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.92e-05 | 175 | 101 | 5 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.34e-05 | 178 | 101 | 5 | 0e1bedf991189d0ef9b40dac9281bdf4739333a1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-05 | 180 | 101 | 5 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | Control-Myeloid-DC1|Control / Condition, Lineage and Cell class | 5.78e-05 | 181 | 101 | 5 | 5a2a1f017ad23baed9972c68b4a46f4c618ef21a | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.93e-05 | 182 | 101 | 5 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 182 | 101 | 5 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 5.93e-05 | 182 | 101 | 5 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.09e-05 | 183 | 101 | 5 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.09e-05 | 183 | 101 | 5 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.41e-05 | 185 | 101 | 5 | 282b3de8850f3c21704339e8d8737b432a43441a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.41e-05 | 185 | 101 | 5 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 187 | 101 | 5 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 6.74e-05 | 187 | 101 | 5 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 187 | 101 | 5 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 187 | 101 | 5 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 187 | 101 | 5 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.91e-05 | 188 | 101 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.09e-05 | 189 | 101 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.27e-05 | 190 | 101 | 5 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.45e-05 | 191 | 101 | 5 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.45e-05 | 191 | 101 | 5 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-05 | 191 | 101 | 5 | d6e158f16a183c9203c057192342e9b83e79bc89 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.45e-05 | 191 | 101 | 5 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-05 | 191 | 101 | 5 | 7cb5c6f2cf27f3503d1b313e402a7410dfe6473e | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 7.45e-05 | 191 | 101 | 5 | e642fa7395c05fb53324c9d46bbc52f89fc9673f | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 7.45e-05 | 191 | 101 | 5 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.45e-05 | 191 | 101 | 5 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.45e-05 | 191 | 101 | 5 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.45e-05 | 191 | 101 | 5 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 7.64e-05 | 192 | 101 | 5 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 7.64e-05 | 192 | 101 | 5 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 7.64e-05 | 192 | 101 | 5 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.82e-05 | 193 | 101 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.82e-05 | 193 | 101 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_DC1|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.82e-05 | 193 | 101 | 5 | 42775588e788c330aade07e54b208f1c2eea3ab3 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.02e-05 | 194 | 101 | 5 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 8.02e-05 | 194 | 101 | 5 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.02e-05 | 194 | 101 | 5 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 8.21e-05 | 195 | 101 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 8.21e-05 | 195 | 101 | 5 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 8.21e-05 | 195 | 101 | 5 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.21e-05 | 195 | 101 | 5 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 8.21e-05 | 195 | 101 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-05 | 196 | 101 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.41e-05 | 196 | 101 | 5 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 8.41e-05 | 196 | 101 | 5 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.62e-05 | 197 | 101 | 5 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | distal-Hematologic-Platelet/Megakaryocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.62e-05 | 197 | 101 | 5 | 751ffb8792058384079ebfe94872b3525f1aea84 | |
| ToppCell | distal-Hematologic-Platelet/Megakaryocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.62e-05 | 197 | 101 | 5 | e28b1b154d9588dce07c123b36f7f01fa90a5fc1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.62e-05 | 197 | 101 | 5 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 8.62e-05 | 197 | 101 | 5 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 8.83e-05 | 198 | 101 | 5 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 8.83e-05 | 198 | 101 | 5 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 8.83e-05 | 198 | 101 | 5 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 198 | 101 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 8.83e-05 | 198 | 101 | 5 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.83e-05 | 198 | 101 | 5 | cd876fba12ff30b74aa507286cb1f3a867011a92 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.83e-05 | 198 | 101 | 5 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.83e-05 | 198 | 101 | 5 | bcfe7b6d91f2e2f145cb2660b65fd2a6c1134b86 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.04e-05 | 199 | 101 | 5 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.04e-05 | 199 | 101 | 5 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.04e-05 | 199 | 101 | 5 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 9.04e-05 | 199 | 101 | 5 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.04e-05 | 199 | 101 | 5 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | Biopsy_Other_PF-Epithelial-Proliferating_Epithelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 9.04e-05 | 199 | 101 | 5 | d73667e2e93026d95184e24ff0bc90afd1fb74a9 | |
| ToppCell | distal-Epithelial-Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.04e-05 | 199 | 101 | 5 | 6ce0df4a6f4d9353919e26ffab97c9ec89911da6 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 9.25e-05 | 200 | 101 | 5 | 5f2fbd789cc16af411a01c3199583888b260ae91 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.25e-05 | 200 | 101 | 5 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells-Neuroepithelial_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | c88d8e67647c90d1fa2569516865a9fd766eaf1c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| ToppCell | distal-3-Hematologic-Platelet/Megakaryocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.25e-05 | 200 | 101 | 5 | f5f5a8b0e4d802d95dc42646dd5e7d7daaad72b4 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.25e-05 | 200 | 101 | 5 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.25e-05 | 200 | 101 | 5 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | 9.25e-05 | 200 | 101 | 5 | 381bafdde6492f020ae93ab8fffa6215c631c570 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 28935053cd6918cd2e9f3e7691f8522216585cb6 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.25e-05 | 200 | 101 | 5 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| Disease | Medulloblastoma | 2.07e-05 | 50 | 95 | 4 | C0025149 | |
| Disease | mean corpuscular hemoglobin concentration | RAD52 CUX2 GLS2 SCG5 COBLL1 TNRC6B EZH1 LEPR FAM222B AFF1 ASXL2 ALAS2 VPS13B | 5.38e-05 | 1105 | 95 | 13 | EFO_0004528 |
| Disease | colon adenocarcinoma (is_implicated_in) | 7.97e-05 | 26 | 95 | 3 | DOID:234 (is_implicated_in) | |
| Disease | smoking cessation | 8.89e-05 | 325 | 95 | 7 | EFO_0004319 | |
| Disease | age at diagnosis, substance-related disorder | 1.53e-04 | 6 | 95 | 2 | EFO_0004918, MONDO_0002494 | |
| Disease | Meckel syndrome (implicated_via_orthology) | 2.84e-04 | 8 | 95 | 2 | DOID:0050778 (implicated_via_orthology) | |
| Disease | valine measurement | 2.93e-04 | 40 | 95 | 3 | EFO_0009792 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 3.05e-04 | 181 | 95 | 5 | DOID:684 (is_implicated_in) | |
| Disease | Combined immunodeficiency | 3.15e-04 | 41 | 95 | 3 | C0494261 | |
| Disease | Childhood Medulloblastoma | 3.63e-04 | 43 | 95 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 3.63e-04 | 43 | 95 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 3.63e-04 | 43 | 95 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 3.63e-04 | 43 | 95 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 3.63e-04 | 43 | 95 | 3 | C0278876 | |
| Disease | glucagon-like peptide-1 measurement | 4.54e-04 | 10 | 95 | 2 | EFO_0008465 | |
| Disease | C-reactive protein measurement | ZSWIM8 CUX2 GLS2 COBLL1 CAST ZCCHC2 LEPR ACOD1 YEATS2 ZNF608 DNAH17 MAML3 | 4.93e-04 | 1206 | 95 | 12 | EFO_0004458 |
| Disease | red blood cell density measurement | 5.43e-04 | 880 | 95 | 10 | EFO_0007978 | |
| Disease | waist-hip ratio | CUX2 GLS2 COBLL1 TNRC6B IQCN RFX7 EZH1 BIRC6 STAT5B YEATS2 DNAH17 MAML3 | 5.70e-04 | 1226 | 95 | 12 | EFO_0004343 |
| Disease | lymphocyte count | UBAP2 COBLL1 TNRC6B WDR27 DAP RFX7 LEPR STAT5B CCDC66 BRD2 DNAH17 AFF1 ZC3HAV1 | 8.25e-04 | 1464 | 95 | 13 | EFO_0004587 |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 9.22e-04 | 59 | 95 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 1.69e-03 | 19 | 95 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 1.69e-03 | 19 | 95 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | wellbeing measurement, alcohol consumption measurement | 1.78e-03 | 74 | 95 | 3 | EFO_0007869, EFO_0007878 | |
| Disease | reticulocyte count | RAD52 UBAP2 GLS2 COBLL1 TNRC6B USP37 BIRC6 DNAH17 ASXL2 ZC3HAV1 | 1.98e-03 | 1045 | 95 | 10 | EFO_0007986 |
| Disease | reticulocyte measurement | RAD52 UBAP2 GLS2 COBLL1 TNRC6B USP37 BIRC6 DNAH17 ASXL2 ZC3HAV1 | 2.09e-03 | 1053 | 95 | 10 | EFO_0010700 |
| Disease | cognitive function measurement | CELF4 ZCCHC2 BIRC6 SHISA9 CCDC66 C1orf21 CSE1L PDLIM3 ZNF608 DNAI4 ASXL2 MAML3 | 2.18e-03 | 1434 | 95 | 12 | EFO_0008354 |
| Disease | gamma-glutamylglutamine measurement | 2.27e-03 | 22 | 95 | 2 | EFO_0021138 | |
| Disease | prostate carcinoma | 2.32e-03 | 891 | 95 | 9 | EFO_0001663 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.38e-03 | 566 | 95 | 7 | EFO_0007660, EFO_0008354 | |
| Disease | monocyte measurement | 2.38e-03 | 82 | 95 | 3 | EFO_0803547 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.93e-03 | 301 | 95 | 5 | DOID:684 (is_marker_for) | |
| Disease | pulmonary embolism | 2.93e-03 | 25 | 95 | 2 | EFO_0003827 | |
| Disease | age at menopause | 2.97e-03 | 302 | 95 | 5 | EFO_0004704 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NKQHSPIQVPMVAGS | 86 | Q8N9N5 | |
| SNPNPVVQMSVGHKA | 556 | A0FGR8 | |
| MDKHPSPRTQHIQQP | 86 | P51397 | |
| SHQKPPQGMEIKSNE | 256 | O95394 | |
| NMIISHKPPSAQQPG | 71 | A8MTB9 | |
| QHSPQVGPTATQAMQ | 2776 | Q9NR09 | |
| QPIHNLMKGNEASPN | 526 | Q96NH3 | |
| ARLISHGPMPQNKQS | 221 | Q9NP70 | |
| QISPNKKAHPNMEAG | 81 | P49662 | |
| TKQGENEHMPVNNPS | 6 | A8MVX0 | |
| PAHQAMNLVGPQSIE | 61 | P05408 | |
| MAGALHPSAKVNPNL | 1441 | O14529 | |
| EQNHIKFKPNTPIGM | 106 | Q53SF7 | |
| VNNPNVKEHPGALSM | 361 | Q6P1M9 | |
| QAMNPSSHGQTIPVQ | 1371 | Q76L83 | |
| MKATGPHNAQTQVNP | 101 | Q86UQ8 | |
| VQDSGQTIPKAQQMH | 71 | P78406 | |
| QTIPKAQQMHTGPVL | 76 | P78406 | |
| DVHPAPTVQQMSSPK | 1036 | Q5T481 | |
| NMALGHPQLQQVTSP | 211 | P43351 | |
| QMHPVTTPAKNPLQT | 456 | Q9H0B3 | |
| GNNVPGNPKNLHMTS | 1521 | Q9ULG1 | |
| APVANTQGPNHKMVS | 1071 | Q14207 | |
| SQPQQPSHPGKMQEA | 206 | Q5VYV0 | |
| ATMDSPPHQKQPQRG | 1816 | Q14676 | |
| VNSAITQQHPQMKGP | 921 | Q96JK9 | |
| TQQHPQMKGPVGQAL | 926 | Q96JK9 | |
| KGPEHMQSLSQQAPK | 761 | Q68CZ1 | |
| NMLTVPHVPKVSQEG | 1011 | Q68CZ1 | |
| GTQLPPMHQQQSRSV | 86 | Q96AE4 | |
| PGVALHNSVQPTAMI | 766 | Q86Z02 | |
| PPMKEHLQLGVNNTK | 3001 | Q03001 | |
| PNQQPSHKIQITMGS | 4486 | Q2LD37 | |
| MKVPGSRTPGHQENN | 1136 | O15550 | |
| SPHQIGIKQILPHQM | 361 | Q969U6 | |
| GIKQILPHQMTTAGP | 366 | Q969U6 | |
| HMPCVQVEANVNKPS | 1006 | Q6ZU69 | |
| PMAQTQGLVHPQALA | 201 | Q8WU58 | |
| FPNMAAKVNGNPHST | 461 | Q96I24 | |
| DSPLVPQKGSFQMVH | 171 | P48357 | |
| IPHNPMVNAGAIVVS | 261 | Q9UI32 | |
| MHSSIPSIENKPPQA | 681 | Q8NDX5 | |
| SGKVTHLIQNNMPGN | 126 | P22557 | |
| KMQEHSDQVPVGNIP | 236 | P33993 | |
| HFQGKTESEPGQQPM | 641 | Q7L8L6 | |
| KAAMPVAQHLNPVQV | 436 | A1L0T0 | |
| VIHSPMGQPHAPQSQ | 386 | Q6AI39 | |
| VLKHENTVPPQSMGA | 96 | Q9BX69 | |
| NAIKITNEPPTGMHA | 3986 | Q9UFH2 | |
| VNGMQPHGVPDKSSV | 801 | Q9HCG7 | |
| ATAHVSQDQKMEPQP | 1216 | Q8N3K9 | |
| MPHENPASGKVSQVG | 346 | P51810 | |
| GSKQKVQQHQQYPMP | 21 | O15063 | |
| PNFPVSVLQNGVKMT | 3526 | Q8WXX0 | |
| NKEVPGLVHQPRANM | 76 | Q9H246 | |
| HIQKEISPATPNMQK | 106 | A2RUB6 | |
| TKAIPVSQQMEGPHL | 6 | P20810 | |
| TMPVSPAGSHKQQNF | 41 | Q5VTH9 | |
| GIKIINHPTMPNTQV | 61 | Q08050 | |
| GAPMANAATQTKPLH | 196 | A6NK06 | |
| QAQPKPDVQHTQHPM | 1011 | Q7Z589 | |
| SIKITNEPPTGMHAN | 4011 | Q9NYC9 | |
| FHKTPEGPGNMEQIQ | 286 | Q6P6B1 | |
| SSIVIPAQHMLPGQN | 456 | Q9NZM4 | |
| PHKGKENTDSVVMQP | 766 | Q03701 | |
| IKNQPLPGSNMIHGT | 1886 | P56715 | |
| GTTNQPVKMTPNHGL | 1656 | Q8NEY1 | |
| TNHDIVKPVVNNNMG | 966 | Q6P4F7 | |
| VSAMQLHPVQGQKLS | 1056 | A5PLK6 | |
| NTVKQTPNHIPSTIM | 501 | O60279 | |
| HLNPSGTMNPTEQEK | 1891 | Q8N4C6 | |
| QATPLMHTKPNSQGP | 721 | Q68EM7 | |
| VSQVPQGHLQSMPTG | 1046 | Q5VVP1 | |
| MRQDPVVHLSPNKQG | 1261 | O43166 | |
| NNAVPTSPLLQQMGH | 236 | B4DS77 | |
| VGGKLNVHMNPPQVK | 356 | P51692 | |
| NVHMNPPQVKATIIS | 361 | P51692 | |
| PGVKIVHAQFNTPMQ | 181 | Q53GG5 | |
| PVNTHQEQMKQPTPL | 26 | P07476 | |
| KVLTQMGSPHNPISS | 451 | O15198 | |
| VGGKLNVHMNPPQVK | 356 | P42229 | |
| NVHMNPPQVKATIIS | 361 | P42229 | |
| MLQNVTPHNKLPGEG | 1 | P25440 | |
| VGNISHNPKMAQPRT | 126 | P51825 | |
| HEQKTLPGMNRPIQV | 116 | Q9BZC1 | |
| MHNGAQKSEVVVPAP | 726 | Q9C0B9 | |
| MFVPPASAKQHGVNL | 931 | Q5T6F2 | |
| TNSPVHKQPSGMNIS | 1106 | Q6ZU65 | |
| PVGQMVNNPKIHLAQ | 916 | P55060 | |
| VIQFMKHTDPQISGP | 636 | Q9UQR0 | |
| RPHMPQQQHKVSPAS | 31 | Q9NX95 | |
| PALGTPKQQLHTMAQ | 351 | Q9H0E3 | |
| QPVQSMKPVSGHPFL | 66 | Q92800 | |
| VTQHMQSVKQAPKTP | 301 | Q2KHR2 | |
| QQSSAQDMHVPVPKQ | 1461 | Q4KWH8 | |
| SINPPALVHVHMQGQ | 126 | Q8NAM6 | |
| QIGFHLSATVVPPQM | 151 | A7E2V4 | |
| AVHQNRLPAAMKPSQ | 101 | Q86T82 | |
| VQIQTHPVNQMAKGT | 791 | P33981 | |
| NGQAPMAPLHVLTQN | 911 | Q9ULD9 | |
| LSGGKQVLPMQVTQH | 3561 | Q7Z7G8 | |
| NSEMTEHFPQKQPQG | 271 | Q86YA3 | |
| VQQMKRGPDHQPAKT | 691 | Q7Z2W4 | |
| HQPITAMAFGNKVNP | 71 | A2RRH5 | |
| QTQGHFQLQLPPGKM | 1291 | P01266 | |
| APHTMIQQPVKSFPT | 641 | Q69YN4 | |
| GNQLPMQVQSALHSP | 446 | O94900 | |
| GHMIAVSPQKQVITP | 621 | Q9ULM3 | |
| MQLGEHTHPQKNPKS | 1 | Q6ZTC4 | |
| QQQRQPGMKHSPSHP | 1326 | Q9UPQ9 |